At ConvEyXo, we release therapeutic exosomes full potential through a versatile and proprietary technology platform and therapeutics development. Senior R&D manager, PhD in Cellular and Molecular Bioengineering from Université de Liege (ULg) in Belgium. 2011-2014: translational research in the academic (ULg, UPenn, UBC), focused on discovery of biomarkers and drug targets in biopsies and clinical cohorts and development of bioassays using tumoral and primary cells.Since 2014: industrial R&D activities in Biotech and Biopharma product and process development (StratiCELL, Orgenesis, Theracell, ConvEyXo). First author or co-author of +30 scientific articles published in peer-reviewed journals, most of them focused on biomarkers, therapeutics, bioassays and cell molecular pathways.Instrumental in the development of several bioassays and manufacturing processes including primary cells, induced pluripotent stem cells (iPSCs), reconstructed human tissues. Instrumental in the inception and coordination of several R&D programs (cumulative budgets >6M€). Experienced R&D manager with recognised contribution in market growth and a profound entrepreneurial mindset.